肝脏MRI特异性对比剂在肝脏肿瘤患者肝功能评价的应用价值
|
摘要
目的研究探讨在肝脏肿瘤病患肝功能评价中应用肝脏MRI特异性对比剂的临床应用价值。方法选取肝脏肿瘤病患25例,按照Child-Pugh分级法将肝脏肿瘤病患进行分组,分为A组、B组、C组,另外选取一组肝肾功能生化检查正常、未合并肝肾功能基础疾病的15例健康体检人员作为对照组,计算并对比各组的肝脏相对增强程度(IS%)。结果对照组IS%与A、B、C三组病患比较均有明显差异(P<0.05);A组病患IS%与B、C三组病患比较均有明显差异(P<0.05)。结论在肝脏肿瘤病患肝功能评价中应用肝脏MRI特异性对比剂,能够对病患的肝细胞功能进行有效反映,临床应用价值较高。
Objective To investigate the clinical application value of liver MRI specific contrast agent in liver function evaluation of liver tumor patients. Methods Twenty-five patients with liver tumors were selected. The patients with liver tumors were divided into group A, group B and group C according to Child-Pugh classification method. In addition, a group of 15 healthy persons with normal biochemical examination of liver and kidney function and without basic diseases of liver and kidney function were selected as the control group. To calculate and compare the relative enhancement of liver(IS%) in each group. Results The IS% of the control group were significantly different from those of group A, B and C(P<0.05). The IS% of the patients in the group A were significantly different from those of group B and C(P<0.05). Conclusion The application of liver MRI specific contrast agent in liver function evaluation of liver tumor patients can effectively reflect the liver cell function of patients, and the clinical application value is higher.
Objective To investigate the clinical application value of liver MRI specific contrast agent in liver function evaluation of liver tumor patients. Methods Twenty-five patients with liver tumors were selected. The patients with liver tumors were divided into group A, group B and group C according to Child-Pugh classification method. In addition, a group of 15 healthy persons with normal biochemical examination of liver and kidney function and without basic diseases of liver and kidney function were selected as the control group. To calculate and compare the relative enhancement of liver(IS%) in each group. Results The IS% of the control group were significantly different from those of group A, B and C(P<0.05). The IS% of the patients in the group A were significantly different from those of group B and C(P<0.05). Conclusion The application of liver MRI specific contrast agent in liver function evaluation of liver tumor patients can effectively reflect the liver cell function of patients, and the clinical application value is higher.
引文
[1]吴娇艳,刘影.探讨肝脏特异性对比剂评价肝功能的价值[J].临床放射学杂志,2018,37(6):962-966.
[2]刘宁川,任龙,王杰春,等.肝脏MRI特异性对比剂在肝脏肿瘤患者肝功能评价的应用价值[J].影像研究与医学应用,2018,2(20):27-28.
[3]叶文宏,汪苍,方佃刚,等.CT及MRI诊断小儿肝脏肿瘤的临床应用价值[J].肝脏,2016,21(6):477-480.
[4]高大海.多层螺旋CT与MRI在肝脏肿瘤鉴别诊断中的应用价值[J].中国医疗器械信息,2017,23(15):64-65.
[5]黎美玲,陆健,曹鹏.动态对比增强MRI在肝脏中的应用与研究进展[J].中国医学影像技术,2017,33(1):149-152.
[6]李娜.浅析肝脏肿瘤多层螺旋CT与MRI影像学特点及鉴别价值比较[J].中国医疗器械信息,2017,23(22):24-25.
[7]牛亚峰,项坤,孙秋原,等.多层螺旋CT及MRI在肝脏肿瘤诊断鉴别中的临床应用[J].肝脏,2017,22(1):84-86.
[8]王凡.探讨肝脏增强CT与肝脏MRI在肝癌诊断中的应用价值[J].中国实用医药,2016,11(9):84-85.
[9]李丰章,胡含明,巫启恒,等.MSCT及MRI动态增强扫描在肝脏局灶性结节增生中的应用[J].当代医学,2017,23(26):69-71.
[10]金志卿.肝脏MRI与增强CT在113例肝癌患者诊断准确率方面的对比研究[J].中外医学研究,2016,14(22):53-55.
[2]刘宁川,任龙,王杰春,等.肝脏MRI特异性对比剂在肝脏肿瘤患者肝功能评价的应用价值[J].影像研究与医学应用,2018,2(20):27-28.
[3]叶文宏,汪苍,方佃刚,等.CT及MRI诊断小儿肝脏肿瘤的临床应用价值[J].肝脏,2016,21(6):477-480.
[4]高大海.多层螺旋CT与MRI在肝脏肿瘤鉴别诊断中的应用价值[J].中国医疗器械信息,2017,23(15):64-65.
[5]黎美玲,陆健,曹鹏.动态对比增强MRI在肝脏中的应用与研究进展[J].中国医学影像技术,2017,33(1):149-152.
[6]李娜.浅析肝脏肿瘤多层螺旋CT与MRI影像学特点及鉴别价值比较[J].中国医疗器械信息,2017,23(22):24-25.
[7]牛亚峰,项坤,孙秋原,等.多层螺旋CT及MRI在肝脏肿瘤诊断鉴别中的临床应用[J].肝脏,2017,22(1):84-86.
[8]王凡.探讨肝脏增强CT与肝脏MRI在肝癌诊断中的应用价值[J].中国实用医药,2016,11(9):84-85.
[9]李丰章,胡含明,巫启恒,等.MSCT及MRI动态增强扫描在肝脏局灶性结节增生中的应用[J].当代医学,2017,23(26):69-71.
[10]金志卿.肝脏MRI与增强CT在113例肝癌患者诊断准确率方面的对比研究[J].中外医学研究,2016,14(22):53-55.